Hereditary ovarian carcinomas: clinico-biological features and treatment

被引：4

作者：

Floquet, Anne ^{[1
]}

Stoeckle, Eberhard ^{[2
]}

Croce, Sabrina ^{[3
]}

Longy, Michel ^{[4
]}

Mc Grogan, Gaetan ^{[3
]}

Barouk, Emmanuelle ^{[4
]}

Bubien, Virginie ^{[4
]}

Garbay, Delphine ^{[1
]}

Joly, Eglantine ^{[4
]}

Guyon, Frederic ^{[2
]}

机构：

[1] Inst Bergonie, Dept Med Oncol, F-33076 Bordeaux, France

[2] Inst Bergonie, Dept Chirurg, F-33076 Bordeaux, France

[3] Inst Bergonie, Dept Anatomopathol, F-33076 Bordeaux, France

[4] Inst Bergonie, Unite Oncogenet, F-33076 Bordeaux, France

来源：

BULLETIN DU CANCER | 2014年 / 101卷 / 02期

关键词：

hereditary ovarian cancer; hereditary breast ovarian cancer; Lynch syndrom; Parp inhibitors; EPITHELIAL OVARIAN; BRCA2; MUTATIONS; POLYMERASE INHIBITOR; CANCER; SURVIVAL; WOMEN; RESISTANCE; OLAPARIB; THERAPY; BREAST;

D O I：

10.1684/bdc.2014.1888

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Hereditary ovarian cancers account for 10% of all cases. Two major syndromes with dominant autosomal transmission are identified. The most common one is breast-ovarian cancer syndrome due to BRCA1 and BRCA2 genes mutations, and the Lynch syndrome with mutated MMR genes is the other. Alterations in homologous recombination specifically observed in ovarian cancer with BRCA defects associated to Parp inhibition create a synthetic lethality of special interest. Numerous studies are in progress to explore this promising new approach. Furthermore, it seems that carcinogenesis of these two syndromes are different, suggesting alternative therapeutic options in the near future in order to improve prognosis of ovarian carcinomas.

引用

页码：167 / 174

页数：8

共 50 条

[31] Clinicopathological and molecular features of hereditary leiomyomatosis and renal cell cancer-associated renal cell carcinomas
Furuya, Mitsuko
Iribe, Yasuhiro
Nagashima, Yoji
Kambe, Naotomo
Ohe, Chisato
Kinoshita, Hidefumi
Sato, Chika
Kishida, Takeshi
Okubo, Yoichiro
Numakura, Kazuyuki
Nanjo, Hiroshi
Nakaigawa, Noboru
Makiyama, Kazuhide
Hasumi, Hisashi
Iwashita, Hiromichi
Ohta, Junichi
Kitamura, Hiroshi
Nakajima, Takahiko
Yoshida, Takahiro
Nakagawa, Masahiro
Tanaka, Reiko
Yao, Masahiro
JOURNAL OF CLINICAL PATHOLOGY, 2020, 73 (12) : 819 - 825
[32] Type III hereditary angio-oedema: clinical and biological features in a French cohort
Vitrat-Hincky, V.
Gompel, A.
Dumestre-Perard, C.
Boccon-Gibod, I.
Drouet, C.
Cesbron, J. Y.
Lunardi, J.
Massot, C.
Bouillet, L.
ALLERGY, 2010, 65 (10) : 1331 - 1336
[33] Clinicopathological features and outcomes after radioactive iodine treatment of oncocytic well-differentiated thyroid carcinomas
Amouri, Wissem
Charfeddine, Salma
Charfi, Slim
Jardak, Issam
Boudawara, Tahia
Guermazi, Fadhel
NUCLEAR MEDICINE COMMUNICATIONS, 2019, 40 (09) : 888 - 893
[34] IGFBP-3 in epithelial ovarian carcinoma and its association with clinico-pathological features and patient survival
Katsaros, D
Yu, H
Levesque, MA
Danese, S
Genta, F
Richiardi, G
Fracchioli, S
Khosravi, MJ
Diamandi, A
Gordini, G
Diamandis, EP
Massobrio, M
EUROPEAN JOURNAL OF CANCER, 2001, 37 (04) : 478 - 485
[35] Small Bowel Carcinomas in Coeliac or Crohn's Disease: Clinico-pathological, Molecular, and Prognostic Features. A Study From the Small Bowel Cancer Italian Consortium
Vanoli, Alessandro
Di Sabatino, Antonio
Furlan, Daniela
Klersy, Catherine
Grillo, Federica
Fiocca, Roberto
Mescoli, Claudia
Rugge, Massimo
Nesi, Gabriella
Fociani, Paolo
Sampietro, Gianluca
Ardizzone, Sandro
Luinetti, Ombretta
Calabro, Antonio
Tonelli, Francesco
Volta, Umberto
Santini, Donatella
Caio, Giacomo
Giuffrida, Paolo
Elli, Luca
Ferrero, Stefano
Latella, Giovanni
Ciardi, Antonio
Caronna, Roberto
Solina, Gaspare
Rizzo, Aroldo
Ciacci, Carolina
D'Armiento, Francesco P.
Salemme, Marianna
Villanacci, Vincenzo
Cannizzaro, Renato
Canzonieri, Vincenzo
Bonetti, Luca Reggiani
Biancone, Livia
Monteleone, Giovanni
Orlandi, Augusto
Santeusanio, Giuseppe
Macciomei, Maria C.
D'Inca, Renata
Perfetti, Vittorio
Sandri, Giancarlo
Silano, Marco
Florena, Ada M.
Giannone, Antonino G.
Papi, Claudio
Coppola, Luigi
Usai, Paolo
Maccioni, Antonio
Astegiano, Marco
Migliora, Paola
JOURNAL OF CROHNS & COLITIS, 2017, 11 (08) : 942 - 953
[36] Large Cell Neuroendocrine Carcinoma of the Lung: Clinico-Pathologic Features, Treatment, and Outcomes
Naidoo, Jarushka
Santos-Zabala, Maria L.
Iyriboz, Tunc
Woo, Kaitlin M.
Sima, Camelia S.
Fiore, John J.
Kris, Mark G.
Riely, Gregory J.
Lito, Piro
Iqbal, Afsheen
Veach, Stephen
Smith-Marrone, Stephanie
Sarkaria, Inderpal S.
Krug, Lee M.
Rudin, Charles M.
Travis, William D.
Rekhtman, Natasha
Pietanza, Maria C.
CLINICAL LUNG CANCER, 2016, 17 (05) : E121 - E129
[37] Exploiting the Synergy between Carboplatin and ABT-737 in the Treatment of Ovarian Carcinomas
Jain, Harsh Vardhan
Richardson, Alan
Meyer-Hermann, Michael
Byrne, Helen M.
PLOS ONE, 2014, 9 (01):
[38] Molecular characteristics of papillary thyroid carcinomas without BRAF mutation or RET/PTC rearrangement: relationship with clinico-pathological features
Durand, Stephanie
Ferraro-Peyret, Carole
Joufre, Mireille
Chave, Annie
Borson-Chazot, Francoise
Selmi-Ruby, Samia
Rousset, Bernard
ENDOCRINE-RELATED CANCER, 2009, 16 (02) : 467 - 481
[39] Clinico-radio-pathological Features and Biological Behavior of Breast Cancer in Young Indian Women: A Prospective Study
Sudhir, Rashmi
Sannapareddy, Kamala
Potlapalli, Alekya
Penmetsa, Vidhatri
INDIAN JOURNAL OF RADIOLOGY AND IMAGING, 2021, 31 (02) : 323 - 332
[40] Early-stage diffuse large B cell lymphoma of the head and neck: clinico-biological characterization and 18 year follow-up of 488 patients (IELSG 23 study)
Mian, M.
Capello, D.
Ventre, M. B.
Grazio, D.
Svaldi, M.
Rossi, A.
Tsang, R.
Gospodarowicz, M. K.
Oldani, E.
Federico, M.
Luminari, S.
Marcheselli, L.
Pogliani, E. M.
Rossini, F.
Cabrera, M. E.
Martelli, M.
Gutierrez-Garcia, G.
Busetto, M.
Visco, C.
Fiegl, M.
Rossi, D.
Gaidano, G.
Cavalli, F.
Zucca, E.
Rambaldi, A.
Cortelazzo, S.
ANNALS OF HEMATOLOGY, 2014, 93 (02) : 221 - 231

← 1 2 3 4 5 →